BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

BioMarin Pharmaceutical Inc. – Material Contracts

NASDAQ: BMRN    
Share price (9/30/26): $60.00    
Market cap (9/30/26): $11.6 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 10-Q 8 pages Amicus Therapeutics, Inc. 2025 Equity Incentive Plan Stock Option Award Agreement
12/34/56
EX-10.4
from 10-Q 7 pages Amicus Therapeutics, Inc. 2025 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.3
from 10-Q 17 pages Amicus Therapeutics, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.2
from 10-Q 26 pages BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan
12/34/56
EX-10.18
from 10-K ~5 pages BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation
12/34/56
EX-10.2
from 10-Q 19 pages BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan, as Amended April 1, 2025
12/34/56
EX-10.1
from 8-K 14 pages Tender and Support Agreement
12/34/56
EX-10.22
from 10-K ~5 pages BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation
12/34/56
EX-10.2
from 10-Q 2 pages BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation
12/34/56
EX-10.1
from 8-K 148 pages Material contract
12/34/56
EX-10.2
from 10-Q ~1 page Biomarin Pharmaceutical Inc. Summary of Independent Director Compensation
12/34/56
EX-10.1
from 10-Q 2 pages Amendment to Consulting Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Delivered by E-Mail April 11, 2024 Biomarin Pharmaceutical Inc. 105 Digital Drive Novato, California 94949 Attention: Eric Davis, Chief Legal Officer Email: Edavis@bmrn.com Dear Sirs / Madams
12/34/56
EX-10.1
from 8-K 22 pages Cooperation Agreement
12/34/56
EX-10.3
from 8-K 13 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 11 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 8 pages Separation Agreement and General Release
12/34/56
EX-10.1
from 10-Q 22 pages Biomarin Pharmaceutical Inc. 2017 Equity Incentive Plan, as Amended April 3, 2023
12/34/56
EX-10.37
from 10-K 6 pages Biomarin Pharmaceutical Inc. 2017 Equity Incentive Plan Stock Option Award Agreement
12/34/56
EX-10.36
from 10-K 5 pages Biomarin Pharmaceutical Inc. 2017 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56